MarketScreener Strategies Celltrion, Inc. Korea S.E.
Equities
068270
KR7068270008
End-of-day quote
Other stock markets
|
||
- KRW | - |
May. 24 | Celltrion Receives European Commission Approval of Omlyclo® (CT-P39), the First and Only Omalizumab Biosimilar Approved in Europe | CI |
May. 10 | Celltrion's Q1 Attributable Profit Slumps 86% | MT |
- Stock Market
- Equities
- A068270 Stock
- 068270 Stock
- News Celltrion, Inc.
- MarketScreener Strategies